Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hans-Peter Rudolf Insider Profile
4 Followers
Hans-Peter Rudolf, Chief Financial Officer at Shield Therapeutics, holds ― shares in Shield Therapeutics (Ticker: GB:STX). Most recently, Hans-Peter Rudolf Bought 1,359,434p shares of Shield Therapeutics on Dec 13, 2022 for an estimated value of 81.57K.
Hans-Peter Rudolf has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Hans-Peter Rudolf does not currently own shares as a corporate insider.
A breakdown of Hans-Peter Rudolf's holdings
Insider Roles
Chief Financial Officer
Roles that Hans-Peter Rudolf holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Hans-Peter Rudolf
Hans-Peter Rudolf's Trading History
List of latest transactions for each holding click on a transaction to see Hans-Peter Rudolf's performance on stock
You May Also Like
Hans-Peter Rudolf insider profile FAQ
What is the percentage of profitable transactions made by Hans-Peter Rudolf?
The percentage of profitable transactions made by Hans-Peter Rudolf is ―.
What is the average return per transaction made by Hans-Peter Rudolf?
The average return per transaction made by Hans-Peter Rudolf is ―.
What stocks does Hans-Peter Rudolf hold?
Hans-Peter Rudolf holds: GB:STX stocks.
What was Hans-Peter Rudolf’s latest transaction?
Hans-Peter Rudolf latest transaction was an Informative Buy of 81.57K.
What was Hans-Peter Rudolf's most profitable transaction?
Hans-Peter Rudolf’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Hans-Peter Rudolf's role in Shield Therapeutics?
Hans-Peter Rudolf's role in Shield Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.